Your browser doesn't support javascript.
loading
Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis: The RINOMAX Randomized Clinical Trial.
Piehl, Fredrik; Eriksson-Dufva, Ann; Budzianowska, Anna; Feresiadou, Amalia; Hansson, William; Hietala, Max Albert; Håkansson, Irene; Johansson, Rune; Jons, Daniel; Kmezic, Ivan; Lindberg, Christopher; Lindh, Jonas; Lundin, Fredrik; Nygren, Ingela; Punga, Anna Rostedt; Press, Rayomand; Samuelsson, Kristin; Sundström, Peter; Wickberg, Oskar; Brauner, Susanna; Frisell, Thomas.
Afiliação
  • Piehl F; Department of Neurology, Karolinska University Hospital, Stockholm, Sweden.
  • Eriksson-Dufva A; Neuroimmunology Unit, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Budzianowska A; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Feresiadou A; Department of Neurology, Karolinska University Hospital, Stockholm, Sweden.
  • Hansson W; Neuroimmunology Unit, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Hietala MA; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Håkansson I; Department of Neurology and Rehabilitation, Ryhov Regional Hospital, Jönköping, Sweden.
  • Johansson R; Department of Neurology, Uppsala University Hospital, Uppsala, Sweden.
  • Jons D; Department of Medical Sciences, Section of Neurology, Uppsala University, Uppsala, Sweden.
  • Kmezic I; Department of Clinical Science, Neurosciences, Umeå University, Umeå, Sweden.
  • Lindberg C; Department of Neurology, Karolinska University Hospital, Stockholm, Sweden.
  • Lindh J; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Lundin F; Department of Neurology, Linköping University Hospital, Linköping, Sweden.
  • Nygren I; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Punga AR; Department of Neurology and Rehabilitation, Central Hospital Karlstad, Karlstad, Sweden.
  • Press R; Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Samuelsson K; Sahlgrenska Academy, Institute of Neuroscience and Physiology, Department of Clinical Neuroscience, Gothenburg University, Gothenburg, Sweden.
  • Sundström P; Department of Neurology, Karolinska University Hospital, Stockholm, Sweden.
  • Wickberg O; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Brauner S; Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Frisell T; Sahlgrenska Academy, Institute of Neuroscience and Physiology, Department of Clinical Neuroscience, Gothenburg University, Gothenburg, Sweden.
JAMA Neurol ; 79(11): 1105-1112, 2022 11 01.
Article em En | MEDLINE | ID: mdl-36121672
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Cuidados_paliativos / Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias do Timo / Miastenia Gravis Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adolescent / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Neurol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Cuidados_paliativos / Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias do Timo / Miastenia Gravis Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adolescent / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Neurol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suécia